•
Nov 1, 2024
Oct 31, 2024
Nov 2, 2024
Oct 30, 2024
Oct 25, 2024
HOOKIPA Pharma Inc. [HOOK] has reported fiscal Q1 loss of $19.70 million.
On a per-share basis, the DE based company said its diluted earnings are $0.27.
The Pharmaceutical Preparations firm posted revenue of $3.20 million in this period.
Also Read: HOOKIPA Pharma Reports First Quarter 2023 Financial Results and Recent Business HighlightsHOOKIPA Announces First Person Dosed in Phase 1a/b Clinical Trial of HB-400, in Collaboration ...HOOKIPA Pharma to Report First Quarter 2023 Financial Results and Recent Business Highlights on ...HOOKIPA to Present a Trial in Progress Poster on its Prostate Cancer Phase 1/2 Clinical Trial ...HOOKIPA Pharma to Participate in the Van Lanschot Kempen Life Sciences Conference